Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop.

Journal

Journal for immunotherapy of cancer
ISSN: 2051-1426
Titre abrégé: J Immunother Cancer
Pays: England
ID NLM: 101620585

Informations de publication

Date de publication:
04 Jul 2019
Historique:
received: 14 06 2019
accepted: 14 06 2019
entrez: 6 7 2019
pubmed: 6 7 2019
medline: 6 7 2019
Statut: epublish

Résumé

Following publication of the original article [1], the author reported that an author name, Roberta Zappasodi, was missed in the authorship list.

Identifiants

DOI: 10.1186/s40425-019-0640-y PMID: 31272507 PMC: PMC6610889
pubmed: 31272507
doi: 10.1186/s40425-019-0640-y
pii: 10.1186/s40425-019-0640-y
pmc: PMC6610889
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

167

Subventions

Organisme : NCI NIH HHS
ID : R01 CA238998
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Commentaires et corrections

Type : ErratumFor

Références

J Immunother Cancer. 2019 May 22;7(1):131
pubmed: 31113486

Auteurs

Davide Bedognetti (D)

Sidra Medicine, Doha, Qatar.

Michele Ceccarelli (M)

AbbVie, Redwood City, CA, USA.

Lorenzo Galluzzi (L)

Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.
Sandra and Edward Meyer Cancer Center, New York, NY, USA.
Université Paris Descartes/Paris V, Paris, France.

Rongze Lu (R)

AbbVie, Redwood City, CA, USA.

Karolina Palucka (K)

The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.

Josue Samayoa (J)

AbbVie, Redwood City, CA, USA.

Stefani Spranger (S)

Koch Institute for Integrative Cancer Research at MIT, Cambridge, MT, USA.

Sarah Warren (S)

NanoString Technologies, Inc, Seattle, WA, USA.

Kwok-Kin Wong (KK)

Perlmutter Cancer Center, New York Langone Health, New York, NY, USA.

Elad Ziv (E)

University of California, San Francisco, CA, USA.

Diego Chowell (D)

Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Lisa M Coussens (LM)

Oregon Health & Science University, Portland, OR, USA.

Daniel D De Carvalho (DD)

Department of Medical Biophysics, Princess Margaret Cancer Centre University Health Network, University of Toronto, Toronto, Canada.

David G DeNardo (DG)

Washington University School of Medicine in St. Louis, St. Louis, MO, USA.

Jérôme Galon (J)

INSERM, Laboratory of Integrative Cancer Immunology, Equipe Labellisée Ligue Contre le Cancer, Sorbonne Université, Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot; Centre de Recherche des Cordeliers, F-75006, Paris, France.

Howard L Kaufman (HL)

Massachusetts General Hospital, Boston, MA, USA and Replimune, Inc, Woburn, MA, USA.

Tomas Kirchhoff (T)

Perlmutter Comprehensive Cancer Center, New York University School of Medicine, New York University Langone Health New York, New York, NY, USA.

Michael T Lotze (MT)

UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.

Jason J Luke (JJ)

University of Chicago, Chicago, IL, USA.

Andy J Minn (AJ)

Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA, USA.

Katerina Politi (K)

Yale School of Medicine, New Haven, CT, USA.

Leonard D Shultz (LD)

The Jackson Laboratory Cancer Center, Bar Harbor, ME, USA.

Richard Simon (R)

R. Simon Consulting, Potomac, MD, USA.

Vésteinn Thórsson (V)

Institute for Systems Biology, Seattle, WA, USA.

Joanne B Weidhaas (JB)

University of California, Los Angeles, Los Angeles, CA, USA.

Maria Libera Ascierto (ML)

MedImmune, Gaithersberg, MD, USA.

Paolo Antonio Ascierto (PA)

Istituto Nazionale Tumori-IRCCS Fondazione 'G. Pascale', Naples, Italy.

James M Barnes (JM)

AbbVie, Redwood City, CA, USA.

Valentin Barsan (V)

Stanford University, Stanford, CA, USA.

Praveen K Bommareddy (PK)

Rutgers University, New Brunswick, NJ, USA.

Adrian Bot (A)

Kite, a Gilead Company, Santa Monica, CA, USA.

Sarah E Church (SE)

NanoString Technologies, Inc, Seattle, WA, USA.

Gennaro Ciliberto (G)

IRCCS Istituto Nazionale Tumori Regina Elena, Rome, Italy.

Andrea De Maria (A)

Università degli Studi di Genova and Ospedale Policlinico San Martino IRCCS, Genoa, Italy.

Dobrin Draganov (D)

Calidi Biotherapeutics, San Diego, CA, USA.

Winson S Ho (WS)

Department of Neurosurgery, Division of Pediatric Neurosurgery, Primary Children's Hospital, University of Utah, Salt Lake City, UT, USA.

Heather M McGee (HM)

Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Anne Monette (A)

Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.

Joseph F Murphy (JF)

Caprion Biosciences Inc, Montreal, QC, Canada.

Paola Nisticò (P)

IRCCS Istituto Nazionale Tumori Regina Elena, Rome, Italy.

Wungki Park (W)

Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Maulik Patel (M)

AbbVie, Redwood City, CA, USA.

Michael Quigley (M)

Bristol-Myers Squibb Company, Redwood City, CA, USA.

Laszlo Radvanyi (L)

Ontario Institute for Cancer Research, Toronto, Ontario, Canada.

Harry Raftopoulos (H)

Bayer HealthCare Pharmaceuticals Inc, Whippany, NJ, USA.

Nils-Petter Rudqvist (NP)

Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.

Alexandra Snyder (A)

Merck & Co, Kenilworth, NJ, USA.

Randy F Sweis (RF)

University of Chicago, Chicago, IL, USA.

Sara Valpione (S)

CRUK Manchester Institute and The Christie NHS Foundation Trust, The University of Manchester, Manchester, UK.

Roberta Zappasodi (R)

Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Lisa H Butterfield (LH)

Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.

Mary L Disis (ML)

University of Washington, Seattle, WA, USA.

Bernard A Fox (BA)

Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Cancer Institute, Portland, OR, USA.

Alessandra Cesano (A)

NanoString Technologies, Inc, Seattle, WA, USA.

Francesco M Marincola (FM)

Refuge Biotechnologies Inc, 1505 Adams Drive, Suite D, Menlo Park, CA, 94025, USA. franco.marincola@refugebiotech.com.

Classifications MeSH